Literature DB >> 6610915

Lymphocyte subpopulations in rheumatoid arthritis. An immunological, enzyme histochemical and morphological study.

F de Vries, C J Meijer, G J Lafeber, J Cnossen, A Cats.   

Abstract

Peripheral blood lymphocytes (PBL) and synovial fluid lymphocytes ( SFL ) of patients with rheumatoid arthritis (RA) were examined with monoclonal antibodies, with coated ox red blood cells for the expression of Fc receptors for IgG or IgM (T mu and T gamma cells), and incubated for the demonstration of alpha- naphtyl acetate esterase and acid phosphatase. Equal percentages of OKT4 and OKT8 PBL were found in clinically active and inactive RA patients, and in healthy controls, but decreased percentages of OKT4 and increased percentages of OKT8-positive lymphocytes were found among the SFL . The percentages of T mu and T gamma cells, the presence of HLA-DR membrane antigens on T lymphocytes as well as the staining pattern for the enzymes revealed that SFL of patients with RA were highly activated, compared to PBL of RA patients and healthy controls. It can be concluded from this study that a single determination of OKT4 and OKT8-positive lymphocytes in the peripheral blood of RA patients has no predictive value for disease activity. However, the results of the experiments on T lymphocyte-activation clearly showed preferential activation of SFL compared to PBL, indicating that activation of lymphocytes occurs at the site of inflammation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6610915     DOI: 10.1007/bf00541203

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  22 in total

1.  Predominantly T-cell infiltrate in rheumatoid synovial membranes.

Authors:  J A Van Boxel; S A Paget
Journal:  N Engl J Med       Date:  1975-09-11       Impact factor: 91.245

2.  Lack of suppressor cell activity in rheumatoid synovial lymphocytes.

Authors:  C Chattopadhyay; H Chattopadhyay; J B Natvig; T E Michaelsen; O J Mellbye
Journal:  Scand J Immunol       Date:  1979       Impact factor: 3.487

Review 3.  The immunopathology of joint inflammation in rheumatoid arthritis.

Authors:  N J Zvaifler
Journal:  Adv Immunol       Date:  1973       Impact factor: 3.543

4.  Separation of functional subsets of human T cells by a monoclonal antibody.

Authors:  E L Reinherz; P C Kung; G Goldstein; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

5.  Receptors for IgM on human lymphocytes. II. Mitogen-induced modulation of receptor expression.

Authors:  P M Lydyard; M W Fanger
Journal:  Clin Exp Immunol       Date:  1979-09       Impact factor: 4.330

6.  T lymphocyte subpopulations in synovial fluid of patients with rheumatic disease.

Authors:  G Biberfeld; E Nilsson; P Biberfeld
Journal:  Arthritis Rheum       Date:  1979-09

7.  Autoantibodies against Tmu and B lymphocytes in patients with rheumatoid arthritis.

Authors:  C J Meijer; J Cnossen; G J Lafeber; M J Damsteeg; A Cats
Journal:  Clin Exp Immunol       Date:  1982-02       Impact factor: 4.330

8.  In situ localization of lymphocyte subsets in synovial membranes of patients with rheumatoid arthritis with monoclonal antibodies.

Authors:  C J Meijer; C B de Graaff-Reitsma; G J Lafeber; A Cats
Journal:  J Rheumatol       Date:  1982 May-Jun       Impact factor: 4.666

9.  Expression of the acid alpha-naphthyl acetate esterase marker by activated and secondary T lymphocytes in man.

Authors:  T H Tötterman; A Ranki; P Häyry
Journal:  Scand J Immunol       Date:  1977       Impact factor: 3.487

10.  Augmented numbers of HLA-DR-positive T lymphocytes in the synovial fluid and synovial tissue of patients with rheumatoid arthritis and juvenile rheumatoid arthritis: in vivo-activated T lymphocytes are potent stimulators in the mixed lymphocyte reaction.

Authors:  O Førre; J H Dobloug; J B Natvig
Journal:  Scand J Immunol       Date:  1982-02       Impact factor: 3.487

View more
  2 in total

1.  Lack of T cell oligoclonality in enzyme-digested synovial tissue and in synovial fluid in most patients with rheumatoid arthritis.

Authors:  J M Van Laar; A M Miltenburg; M J Verdonk; M R Daha; R R De Vries; P J Van den Elsen; F C Breedveld
Journal:  Clin Exp Immunol       Date:  1991-03       Impact factor: 4.330

2.  Correlation of disease activity and drug therapy with the autologous mixed lymphocyte reaction in rheumatoid arthritis.

Authors:  S M Cross; R A Hazelton
Journal:  Ann Rheum Dis       Date:  1985-04       Impact factor: 19.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.